| scholarly article | Q13442814 |
| P2093 | author name string | T Takahashi | |
| K Ueda | |||
| K Kumano | |||
| M Kurokawa | |||
| S Ota | |||
| Y Imai | |||
| M Fukayama | |||
| K Kataoka | |||
| Y Nannya | |||
| S Seo | |||
| K Ohtomo | |||
| E Maeda | |||
| A Hangaishi | |||
| T Watadani | |||
| P2860 | cites work | Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 |
| Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation | Q34396430 | ||
| Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis | Q34468742 | ||
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
| Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling | Q34487398 | ||
| Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria | Q34565524 | ||
| Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. | Q35745142 | ||
| Airways obstruction associated with graft versus host disease after bone marrow transplantation | Q36141709 | ||
| Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality | Q36715387 | ||
| Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation | Q36853940 | ||
| Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies | Q37340630 | ||
| The pathologist's approach to small airways disease | Q37383452 | ||
| Pulmonary complications of bone marrow transplantation | Q39492652 | ||
| NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation | Q40912560 | ||
| Fatal airway disease in an adult with chronic graft-versus-host disease | Q41118877 | ||
| Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation | Q41457039 | ||
| Clinical course of idiopathic pneumonia after bone marrow transplantation | Q42622942 | ||
| Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. | Q44750603 | ||
| Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant | Q45121795 | ||
| High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children | Q46503110 | ||
| Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. | Q46952765 | ||
| Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. | Q51659830 | ||
| Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. | Q51681296 | ||
| Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P). | Q54676818 | ||
| Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation | Q57221179 | ||
| Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation | Q58416037 | ||
| Risk factors for airflow obstruction in recipients of bone marrow transplants | Q68193104 | ||
| Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors | Q68860207 | ||
| Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course | Q69528916 | ||
| Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings | Q73893409 | ||
| Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation | Q74412190 | ||
| Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation | Q79924681 | ||
| Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia | Q80345532 | ||
| Cryptogenic organizing pneumonia | Q81025548 | ||
| Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning | Q81685802 | ||
| In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation | Q81778094 | ||
| ??? | Q28215495 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1719-1727 | |
| P577 | publication date | 2010-03-08 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT. | |
| P478 | volume | 45 |
| Q90428326 | Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally |
| Q43184646 | Exploring the possibilities: airspace disease in the postallogeneic haematopoietic stem cell transplant period |
| Q35813877 | Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis. |
| Q36540556 | Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation. |
Search more.